CYT-1853

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCYT-1853
Drug Alias NameCYT-1853
ClassificationSmall molecules
Mechanisms of ActionDNA repair protein RAD51 homolog 1 inhibitors
TargetsDNA repair protein RAD51 homolog 1
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyteir Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyteir Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A